Male infertility has four common causes that together account for most diagnosed cases: sperm production failure at the testicular level, obstruction or absence of the sperm-delivery ducts, hormonal signaling faults along the hypothalamic-pituitary-gonadal axis, and varicocele — a dilated vein cluster in the scrotum that raises testicular temperature. Roughly 1 in 7 couples worldwide cannot conceive within five years, per the World Health Organization, and a male factor contributes in about half of those cases, either alone or alongside a female factor. Each of these four mechanisms disrupts sperm at a different point, which is why two men with the same "infertility" label can need completely different treatments.
How Sperm Production Works and Where It Breaks
Spermatogenesis is a 74-day assembly line. Spermatogonia at the base of the seminiferous tubule divide and mature into sperm, then spend another 10 to 14 days transiting the epididymis to gain motility. Total turnaround from stem cell to ejaculate: roughly 90 days. That single number explains two clinical facts. First, any treatment — hormones, varicocele repair, stopping heat exposure — needs about three months before a repeat semen analysis can fairly judge it. Second, a toxic exposure or fever in week one shows up in the ejaculate only ten weeks later.
The factory runs on testosterone produced by Leydig cells, but it needs testosterone at a concentration 25 to 100 times higher inside the tubule than in the blood. FSH then drives maturation. The system is temperature-sensitive: the scrotum holds the testicles 2 to 4 degrees Fahrenheit below core body temperature, and every step of sperm production degrades as that gradient shrinks. In plain terms: the testicles are a refrigerated workshop, and most of the four causes below either damage the machinery, block the exit, or break the thermostat.
Cause 1: Impaired Sperm Production (Non-Obstructive Azoospermia and Oligospermia)
This is the largest bucket. The World Health Organization's 2021 laboratory manual sets the lower reference limit for sperm concentration at 16 million per milliliter and total sperm count at 39 million per ejaculate, derived from men whose partners conceived within 12 months. Below those thresholds, production is impaired; at zero, the diagnosis is azoospermia. About 1 percent of all men and up to 15 percent of infertile men have azoospermia, and roughly 60 percent of those cases are non-obstructive — the testes simply are not producing.
The mechanisms split into three. Genetic causes include Y-chromosome microdeletions (about 10 to 15 percent of non-obstructive azoospermia) and Klinefelter syndrome, present in roughly 1 in 600 male births. Acquired causes include chemotherapy, testicular torsion, undescended testes not corrected in childhood, and mumps orchitis. Idiopathic failure — no identifiable cause — covers roughly 30 to 40 percent of cases, a reminder that the science here is incomplete rather than settled.
A useful quantified comparison: sperm concentration in a fertile 25-year-old averages around 60 to 70 million per milliliter, while the WHO lower limit sits at 16 million — a fourfold gap. That means a man can be "normal" by guideline and still have one-quarter the concentration of a typical fertile peer. Semen parameters also decline measurably with age, with total motile count falling roughly 0.7 to 1 percent per year after age 35 in large cohort studies.
Cause 2: Duct Obstruction and Sperm Delivery Failure
Here production may be perfectly normal, but the plumbing is blocked. Obstructive azoospermia accounts for about 40 percent of zero-sperm cases, and it carries a very different prognosis: because the factory works, sperm can often be surgically retrieved directly from the epididymis or testicle and used for IVF with success rates above 50 percent per cycle in many centers. That is a striking asymmetry — two men with identical semen analyses, one obstructive and one not, face success odds that differ by an order of magnitude.
Blockages arise from prior groin surgery (hernia repair, hydrocele repair), pelvic infection, or congenital absence of the vas deferens (CAVD). CAVD deserves special mention because of an edge case clinicians watch for: roughly 1 to 2 percent of men with CAVD carry mutations in the CFTR gene, the same gene behind cystic fibrosis. A man with no vas deferens and no lung symptoms can still be a carrier, which matters for genetic counseling of his partner.
Cause 3: Hormonal Axis Disruption
Sperm production depends on a three-tier signal: the hypothalamus releases GnRH, the pituitary releases LH and FSH, and the testes respond with testosterone and sperm. Break the chain anywhere and production falls. Hypogonadotropic hypogonadism — failure at the brain end — affects roughly 1 in 10,000 to 1 in 86,000 men depending on whether it is congenital, and it is one of the few truly reversible causes: pulsatile GnRH or gonadotropin injections restore fertility in 70 to 95 percent of cases over 12 to 24 months.
The counterintuitive part is exogenous testosterone. Many men take testosterone for low energy or body composition, believing it boosts fertility. It does the opposite. External testosterone raises blood levels enough that the pituitary stops sending LH and FSH, and the testes shut down sperm production — often to zero within 3 to 6 months. This is a corrected misconception worth stating plainly: testosterone therapy is a contraceptive, not a fertility treatment. Recovery after stopping can take 6 to 24 months and is not guaranteed.
Hyperprolactinemia is a rarer hormonal cause, present in under 5 percent of infertile men, but it is important because a prolactin-secreting pituitary tumor is treatable with medication, restoring fertility in most cases.
Cause 4: Varicocele
A varicocele is an abnormal dilation of the pampiniform plexus, the vein network that drains the testicle. It affects roughly 15 percent of all men but 35 to 40 percent of men being evaluated for infertility — a two-and-a-half-fold enrichment that makes it the most common correctable cause. It appears on the left side in about 85 to 90 percent of cases because the left testicular vein drains into the renal vein at a less favorable angle.
The mechanism is worth one level of depth: pooled blood raises scrotal temperature by an estimated 0.5 to 1 degree Fahrenheit, and the countercurrent heat-exchange system that normally cools arterial blood fails. The result is oxidative stress and impaired spermatogenesis. The quantified effect is modest but real — varicocele repair improves total motile sperm count by an average of about 10 to 15 million per ejaculate and yields spontaneous pregnancy in roughly 30 to 40 percent of couples versus 10 to 20 percent with observation, though trials disagree on the size of the benefit. In plain terms: fixing a varicocele helps some couples conceive naturally and helps others qualify for less invasive fertility treatment, but it is not a guaranteed cure.
Comparison Table: The Four Causes at a Glance
| Cause | Share of male infertility | Typical semen finding | Reversible? | First-line approach |
|---|---|---|---|---|
| Impaired production | 60 percent of azoospermia cases | Low count or zero | Partly | Genetic testing, micro-TESE |
| Duct obstruction | 40 percent of azoospermia cases | Zero sperm, normal volume or low volume | Often surgically bypassable | Sperm retrieval plus IVF |
| Hormonal axis disruption | Under 5 percent | Low count, low testosterone | Usually yes | Stop testosterone, gonadotropins |
| Varicocele | 35 to 40 percent of evaluated men | Low motility, low count | Correctable in some | Observation or repair |
Timeline: From Evaluation to Treatment Effect
| Time point | What happens |
|---|---|
| Day 0 | Two semen analyses, 2 to 7 days apart, after 2 to 5 days abstinence |
| Week 1 to 2 | Hormone panel: testosterone, LH, FSH, prolactin; scrotal exam |
| Week 2 to 4 | Genetic testing if count is very low or zero (karyotype, Y-microdeletion) |
| Month 1 to 3 | Varicocele repair or hormonal therapy initiated |
| Month 3 | First repeat semen analysis — one full spermatogenesis cycle |
| Month 6 | Second repeat analysis; assess trajectory |
| Month 9 to 12 | Reassess pregnancy outcome; escalate to assisted reproduction if needed |
The 3-month first checkpoint and 6-month reassessment reconcile with the 74-day production cycle plus 10 to 14 days of epididymal transit: waiting less than 90 days cannot show the full effect of any change, while waiting more than 6 months without improvement signals that the intervention is not working.
Red Flags That Change the Workup
Most male infertility is evaluated electively, but certain findings demand faster action:
- A painless testicular lump or new scrotal mass — rule out testicular cancer before assuming infertility.
- Sudden testicular pain with swelling — possible torsion, a surgical emergency within 6 hours.
- Zero sperm volume with absent vas deferens on both sides — genetic counseling for CFTR.
- Very low testosterone plus visual field changes or headaches — evaluate for pituitary tumor.
- Azoospermia with a normal-volume ejaculate and normal hormones — consider obstruction or retrieval candidacy.
- History of chemotherapy, pelvic radiation, or childhood cancer treatment — sperm banking discussion before any gonadotoxic exposure.
What to Actually Do
Start with two semen analyses and a hormone panel before assuming a cause. If testosterone therapy is underway, stop it and recheck in 3 months, because that single change resolves a subset of cases outright. Ask for a scrotal examination in the standing position with a Valsalva maneuver, since varicoceles are often missed lying down. Bank sperm before any planned chemotherapy, radiation, or groin surgery. Recheck all semen parameters at the 3-month mark, not sooner. For couples without a diagnosis after a full workup, idiopathic male infertility is common, and assisted reproduction remains a valid path rather than a failure of the process.
Limitations of the Evidence
The four-cause framework is a clinical organizing tool, not a complete map. Roughly 30 to 40 percent of male infertility is idiopathic, and the boundaries between causes blur — a varicocele can coexist with a genetic predisposition, and hormonal and production failure often overlap. Varicocele repair outcome data remain contested, with some randomized trials showing pregnancy benefit and others showing none. Sperm retrieval success in non-obstructive azoospermia varies from about 30 to 60 percent depending on center and case mix. The honest position: these four causes explain most cases, guide most first-line decisions, and still leave a meaningful fraction where the mechanism is unknown and treatment is empirical.